Stock PERE PHARP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News PERE PHARP Nasdaq

Equities

US7136614036

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2018 After Market Close on July 16, 2018
GL
Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index
GL
Avid Bioservices to Participate at BIO International Convention 2018
GL
Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences
GL
Avid Bioservices Provides Update on Ongoing Expansion of Process Development Capabilities and Laboratory Infrastructure
GL
Avid Bioservices to Participate at INTERPHEX 2018
GL
Avid Bioservices to Participate at Upcoming CDMO Industry Conferences
GL
Avid Bioservices Reports Financial Results for Third Quarter of Fiscal Year 2018 and Recent Developments
GL
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
GL
Avid Bioservices to Present at the 30th Annual ROTH Conference
GL
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2018 After Market Close on March 12, 2018
GL
Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease Candidate
GL
Avid Bioservices Announces Resignation of Chief Financial Officer
GL
Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences
GL
Avid Bioservices Announces Closing of Public Offering of Common Stock
GL
Avid Bioservices Announces Pricing of Public Offering of Common Stock
GL
Avid Bioservices Announces Proposed Offering of Common Stock
GL
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab
GL
Avid Bioservices to Present at NobleCon14
GL
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. News PERE PHARP